Letters Opening up data at the EMA

EMA urgently needs a cure

BMJ 2011; 342 doi: http://dx.doi.org/10.1136/bmj.d3832 (Published 20 June 2011) Cite this as: BMJ 2011;342:d3832
  1. Alain Braillon, public health1
  1. 180000 Amiens, France
  1. braillon.alain{at}gmail.com

The BMJ has dared to report that the European Medicines Agency (EMA) seems more interested in protecting the secrets of Big Pharma than in protecting the health of the European people.1 2

For …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe